drugset / Trial / NCT05750446

Effect of Riocigaut on Migraine Attack Induction in People With Migraine

NCT05750446

Completed 22 enrolled Danish Headache Center
RandomizedCrossoverQuadruple-blindOther

Summary

This double-blind, randomized, placebo-controlled cross-over clinical trial aims to investigate the effects of riocigaut on migraine inducing properties in people with migraine.

Timeline

Start
2023-06-01
Primary completion
2024-02-01
Completion
2024-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Riociguat Other / unclassified Oral

Indications